San Diego, CA (PRWEB) June 26, 2013
Resource4thePeople today announced its latest update for consumers who are following the consolidated federal court lawsuits* alleging links between Tylenol products and liver cancer.
U.S. District Court Judge Lawrence Stengel of the Eastern District of Pennsylvania in a June 17, 2013 order** has posted the master complaint that contains allegations common to all of the plaintiffs who are suing the drug's manufacturers over these claims.
"This complaint contains a clear and detailed presentation of the allegations that have been made in this multidistrict litigation from victims and loved ones claiming that the use of Tylenol products has caused deaths and serious permanent physical injuries, among other dangerous side effects," said Resource4thePeople.
"We are encouraged by the fact that as this litigation advances the evidence-gathering and legal actions coordinated under the single federal judge overseeing these lawsuits will focus on these allegations."
As this litigation moves forward, Resource4thePeople also announces it is reaffirming its commitment to provide free consultations to consumers who also may have been affected by alleged Tylenol side effects and are seeking to explore their legal options.
"Even though these cases have been consolidated consumers should be aware that this does not prevent them from seeking legal assistance about the possibility of filing their own cases," said Resource4thePeople, which will continue to provide updates about the progress of the litigation.
Named as defendants in the master complaint are pharmaceutical giant Johnson & Johnson and subsidiaries McNeil-PPC, Inc. and McNeil Consumer Healthcare, who have denied the allegations.
"As a direct and proximate result of the acts and omissions of Defendants, and Plaintiffs’ use of Tylenol, Plaintiffs have suffered death, serious permanent physical injury, life-changing, life-altering pain and suffering, loss of income, loss of opportunity, loss of family and social relationships, and medical, hospital, surgical and funeral expenses and other expenses related to diagnosis and treatment thereof, for which Defendants are liable," the plaintiffs claim in their filing. "As a direct and proximate result of Plaintiffs use of Tylenol, Plaintiffs have suffered and will continue to suffer pecuniary and other losses."
The complaint also contains allegations that "Plaintiffs have been prevented from pursuing their normal activities and employment, have experienced severe pain and suffering and mental anguish, and have been deprived of their ordinary pursuits and enjoyments of life."
Also, the complaint alleges, "Plaintiffs' spouses have lost, presently and in the future, their spouse's companionship, services, society and the ability of Plaintiffs' spouses in said respect has been impaired and depreciated, and the marital association between husband and wife has been altered, and as such, the Plaintiffs' spouses have been caused mental anguish and suffering."
Most of the lawsuits alleging links between Tylenol and severe liver damage were filed after a June 24, 2009 safety communication*** (updated on April 11, 2013) was issued by the Food and Drug Administration warning that the painkiller Tylenol (acetaminophen) when taken in doses stronger than the recommended amount can cause life-threatening health problems.
The FDA said it issued the warning after an advisory committee of medical experts and physicians met to address the problem of liver injury related to the use of acetaminophen in both over-the-counter (OTC) and prescription products.
The FDA said acetaminophen is the generic name of a drug found in many common brand name OTC products such as Tylenol, as well as prescription products such as Vicodin and Percocet.
“Acetaminophen is an important drug, and its effectiveness in relieving pain and fever is widely known,” said the FDA. “This drug is generally considered safe when used according to the directions on its labeling. But taking more than the recommended amount can cause liver damage, ranging from abnormalities in liver function blood tests, to acute liver failure, and even death.”
The consolidated cases were assigned to Judge Stengel over the objections of the manufacturers of Tylenol and other acetaminophen-based products, according to an April 5, 2013 Reuters News Service report:****
"A group of drugmakers have lost their bid to prevent the consolidation in federal court of over two dozen personal injury cases involving the painkiller acetaminophen, the latest such defeat for pharmaceuticals seeking to bar the formation of a multidistrict litigation.
"Drugmakers McNeil/Johnson & Johnson, Novartis and L. Perrigo Co had argued that 27 lawsuits claiming that ingesting acetaminophen can cause liver injury lacked sufficient commonality to merit MDL status."
Resource4thePeople has discovered that many of the consumers who have made inquiries over this litigation were unaware of the possible side effects from Tylenol products that allegedly could cause liver damage or failure. These are now being detailed on the Tylenol official web site.*****
Also included on the web site is this warning:
“It is important to be aware of the ingredients in all medications that you may be taking. Acetaminophen (APAP) is a common component of many different over-the-counter and prescription medications. You should not take two or more products that contain acetaminophen at the same time. Taking more than the recommended dose (overdose) of acetaminophen may cause liver damage.”
“These are serious health issues that -- because of the huge popularity of these drugs -- are causing widespread concern among consumers,” said Resource4thePeople “Our attorneys are now actively investigating these claims.”
In seeking consolidation into a multidistrict litigation, attorneys for the plaintiffs alleged that "McNeil marketed and sold its over-the-counter Tylenol products in a manner that concealed the margin of risk of liver toxicity and liver failure,” according to the filings for their petition.******
*In Re: Tylenol (Acetaminophen) Marketing, Sales Practices and Products Liability Litigation; Case 2:2013md02436